2024 Biopharma Investment Outlook with Chris Dokomajilar
Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously researched licensing deal financial comps, up-to-date profiles, and historic company and pipeline data. In this special spotlight episode, we take a deeper dive into the investment landscape for advanced therapies and also AI investment and partnership activity in the biopharma space.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.